Literature DB >> 29850829

High DPP-4 Concentrations in Adolescents Are Associated With Low Intact GLP-1.

Rasmus Stenlid1,2, Hannes Manell1,2, Maria Halldin2, Joel Kullberg3,4, Håkan Ahlström3,4, Levon Manukyan1, Daniel Weghuber5,6, Katharina Paulmichl5,6, Fanni Zsoldos5,6, Peter Bergsten1,2, Anders Forslund2.   

Abstract

Context: Dipeptidyl peptidase 4 (DPP-4) metabolizes glucagon-like peptide-1 (GLP-1), and increased DPP4 levels are associated with obesity and visceral adiposity in adults. Objective: Investigating DPP-4 levels in adolescents and their association with (1) circulating intact GLP-1 levels and glucose tolerance; (2) body mass index (BMI); and (3) visceral, subcutaneous, and liver fat compartments. Design: Cross-sectional study, July 2012 to April 2015. Setting: Pediatric obesity clinic, Uppsala University Hospital. Patients and Participants: Children and adolescents with obesity (n = 59) and lean controls (n = 21) aged 8 to 18 years. Main Outcome Measures: BMI SD score, fasting plasma concentrations of DPP-4, total and intact GLP-1, fasting and oral glucose tolerance test (OGTT) concentrations of glucose, and visceral adipose tissue (VAT) and subcutaneous adipose tissue volumes and liver fat fraction.
Results: Plasma DPP-4 levels decreased with age in both obese (41 ng/mL per year) and lean subjects (48 ng/mL per year). Plasma DPP-4 levels were higher in males in both the obesity and lean groups. With adjustments for age and sex, plasma DPP-4 level was negatively associated with intact GLP-1 at fasting (β = -12.3; 95% CI: -22.9, -1.8) and during OGTT (β = -12.1; 95% CI: -22.5, -1.7). No associations were found between DPP-4 and plasma glucose levels measured at fasting or after a 2-hour OGTT. Plasma DPP-4 level was 19% higher in obese subjects. Among adipose tissue compartments, the strongest association was with VAT (β = 0.05; 95% CI: -0.02, 0.12). Conclusions: In adolescents, high plasma DPP-4 concentrations were associated with low proportions of intact GLP-1, high BMI, young age, and male sex. The observed associations are compatible with increased metabolism of GLP-1 in childhood obesity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29850829     DOI: 10.1210/jc.2018-00194

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.

Authors:  Victoria Higgins; Shervin Asgari; Jill K Hamilton; Anna Wolska; Alan T Remaley; Bolette Hartmann; Jens J Holst; Khosrow Adeli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

2.  Targeting the DPP-4-GLP-1 pathway improves exercise tolerance in heart failure patients: a systematic review and meta-analysis.

Authors:  Chengcong Chen; Ying Huang; Yongmei Zeng; Xiyan Lu; Guoqing Dong
Journal:  BMC Cardiovasc Disord       Date:  2019-12-23       Impact factor: 2.298

3.  DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes.

Authors:  Min Qiu; Shuheng Zhai; Da Liu
Journal:  Int J Endocrinol       Date:  2020-11-27       Impact factor: 3.257

4.  Altered mitochondrial metabolism in peripheral blood cells from patients with inborn errors of β-oxidation.

Authors:  Rasmus Stenlid; David Olsson; Jing Cen; Hannes Manell; Charlotte Haglind; Azazul Islam Chowdhury; Peter Bergsten; Anna Nordenström; Maria Halldin
Journal:  Clin Transl Sci       Date:  2021-08-26       Impact factor: 4.689

5.  Low levels of soluble DPP4 among Saudis may have constituted a risk factor for MERS endemicity.

Authors:  Khaled R Alkharsah; Salma Ali Aljaroodi; Jawad Ur Rahman; Awatif N Alnafie; Reem Al Dossary; Reem Y Aljindan; Amani M Alnimr; Jamal Hussen
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

6.  High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition.

Authors:  Banu Kucukemre Aydin; Rasmus Stenlid; Iris Ciba; Sara Y Cerenius; Marie Dahlbom; Peter Bergsten; Ricard Nergårdh; Anders Forslund
Journal:  Pediatr Obes       Date:  2022-02-28       Impact factor: 3.910

7.  A Physiologically-Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP-1 and GIP and the DPP4 Inhibitor Sitagliptin.

Authors:  Pavel Balazki; Stephan Schaller; Thomas Eissing; Thorsten Lehr
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.